- Research finds that higher levels of the brain chemical GABA can reverse negative effects such as schizophrenia and depression
- Professor Steven Laviolette, who spearheaded the study, hopes that GABA-increasing cannabinoid compounds developed with industrial partners from this research could lead to clinical trials “in the next few years”
- Algae Dynamics Corp. has signed a collaborative agreement with the University of Western Ontario, giving the company the patent rights to any drugs developed as a result of research
Algae Dynamics Corp. (OTCQB: ADYNF) is in a collaboration agreement with the University of Western Ontario (now rebranded as Western University), which is making international news with its recent study in Nature Scientific Reports (http://nnw.fm/aJ7Oh). The study found that the negative effects on the adolescent brain from chronic use of tetrahydrocannabinol (THC)-rich marijuana can be reversed by using compounds which increase the amounts of GABA, a chemical and neurotransmitter in the brain.
The article in Nature Scientific Reports is titled “Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function.” The results have been globally reported by Global News, CBC of London, CTV News and UPI.
Read the full article
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Read More